Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: Feasibility study in rabbits

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 26, Issue 4, 2008, Pages 179-187

  Takamatsu, Shigeyuki ^a   Matsui, Osamu ^a   Gabata, Toshifumi ^a   Kobayashi, Satoshi ^a   Okuda, Miho ^a   Ougi, Takahiro ^a   Ikehata, Yoshio ^a   Nagano, Isamu ^a   Nagae, Hideo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Ferucarbotran; Hyperthermia; Transarterial embolization

Indexed keywords

FERUCARBOTRAN; GELATIN SPONGE; IODINATED POPPYSEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; FEASIBILITY STUDY; HYPERTHERMIC THERAPY; KIDNEY CARCINOMA; MAGNETIC FIELD; MALE; NICK END LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANIMALS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; FEASIBILITY STUDIES; GELATIN SPONGE, ABSORBABLE; HEMOSTATICS; HYPERTHERMIA, INDUCED; IODIZED OIL; IRON; KIDNEY NEOPLASMS; MALE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; OXIDES; RABBITS; SODIUM CHLORIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 44449175617     PISSN: 02882043     EISSN: 18625274     Source Type: Journal    
DOI: 10.1007/s11604-007-0212-9     Document Type: Article

References (22)

1. Kusumoto T, Maehara Y, Baba H, Takahashi I, Kusumoto H, Ohno S. Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells. Br J Cancer 1993;68:259-263.
2. Overgaard J, Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma; European Society for Hyperthermic Oncology. Lancet 1995;345:540-543.
3. Kim BS, Chung HC, Seong JS, Suh CO, Kim GE. Phase II trial for combined external radiotherapy and hyperthermia for unresectable hepatoma. Cancer Chemother Pharmacol 1992;31(suppl):119-127.
4. Barry JW, Bookstein JJ, Alksne JF. Ferromagnetic embolization: experimental evaluation. Radiology 1981;138:341-349.
5. Rand RW, Snow HD, Brown WJ. Thermomagnetic surgery for cancer. J Surg Res 1982;33:177-183.
6. Luderer AA, Borrelli NF, Panzarino JN, Mansfield GR, Hess DM, Brown JL, et al. Glass-ceramic-mediated, magnetic-field-induced hyperthermia: response of a murine mammary carcinoma. Radiat Res 1983;94:190-198.
7. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann Surg 1957;146:596-606.
8. Moroz P, Jones SK, Winter J, Gray BN. Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model. J Surg Oncol 2001;78:22-29.
9. Tazawa K, Nagae H, Takemori S, Yamashita I, Kato H, Okamoto M, et al. A study of inductive heating for cancer with use of dextran magnetite (DM), effect for various cancer cell by intracellular hyperthermia. Jpn J Hypertherm Oncol 1991;7:381-390.
10. Mitsumori M, Hiraoka M, Shibata T, Okuno Y, Masunaga S, Koishi M, et al. Development of intra-arterial hyperthermia using a dextran-magnetic complex. Int J Hyperthermia 1994;10:785-793.
11. Nakamura H, Hashimoto T, Taguchi T, Ohi H, Nakayama K, Inoue K, et al. Chemoembolization. Gan To Kagaku Ryoho 1987;14:1656-1663.
12. Kopp AF, Laniado M, Dammann F, Stern W, Gronewaller E, Balzer T, et al. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 1997;204:749-756.
13. Lawaczeck R, Bauer H, Frenzel M, Hasegawa M, Ito Y, Kito K, et al. Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting: pre-clinical profile of SH U555A. Acta Radiol 1997;38:584-597.
14. Yamazaki Y, Nagano I, Yagitani S, Maeda T, Igarashi K, Terai K, et al. Heating characteristics of dextran magnetite under a strong AC magnetic field created by a portable magnetic generator. J Jpn Soc Appl Electromagn Mech 2003;241-248.
15. Tazawa K, Wada S, Yatsuzuka M, Saito T, Tazawa K, Nagano I, et al. Development of a portable inductive heating system using dextran magnetite complex-heating characteristics in vitro and the antitumor effect in VX-2 tumor-bearing rabbits. Jpn J Hypertherm Oncol 2003;19:79-87.
16. Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz); ICNIRP guidelines. Health Physics 1998;74:494-522.
17. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferromagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993;9:51-68.
18. Mitsumori M, Hiraoka M, Shibata T, Okuno, Nagata Y, Nishimura Y, et al. Targeted hyperthermia using dextran magnetite complex; a new treatment modality for liver tumor. Hepatogastroenterology 1996;43:1431-1437.
19. Kan Z, Ivancev K, Hagerstrand I, Chuang VP, Lunderquist A. In vivo microscopy of the liver after injection of lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol 1989;30:419-425.
20. Kan Z, Sato M, Ivancev K, Uchida B, Hedgpeth P, Lunderquist A, et al. Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species. Radiology 1993;186:861-866.
21. Rosch J, Keller FS, Kozak B, Niles N, Dotter CT. Gelfoam powder embolization of the left gastric artery in treatment of massive small-vessel gastric bleeding. Radiology 1984;151:365-370.
22. Sugimori K, Numata K, Morimoto M, Hirao T, Hirasawa K, Oka I, et al. Radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: CT examination during the follow-up period. Gan To Kagaku Ryoho 2004;31:1733-1736.